At1 Receptor Antagonists Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0064940
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:6.72
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 6.72 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
SummaryAT1 receptor antagonists are a group of pharmaceuticals that modulate the renin-angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The global AT1 Receptor Antagonists market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2026, growing at a CAGR of xx% between 2019 and 2026.
This report studies the AT1 Receptor Antagonists market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of AT1 Receptor Antagonists in these regions, from 2014 to 2026, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
By the product type, the market is primarily split into
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By the end users/application, this report covers the following segments
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global AT1 Receptor Antagonists market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2026.
To understand the structure of AT1 Receptor Antagonists market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global AT1 Receptor Antagonists manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the AT1 Receptor Antagonists with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of AT1 Receptor Antagonists submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of AT1 Receptor Antagonists are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of AT1 Receptor Antagonists market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, we offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of AT1 Receptor Antagonists market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents
1 AT1 Receptor Antagonists Market Overview
1.1 AT1 Receptor Antagonists Product Overview
1.2 AT1 Receptor Antagonists Market Segment by Type
1.2.1 Valsartan
1.2.2 Telmisartan
1.2.3 Losartan
1.2.4 Irbesartan
1.2.5 Azilsartan
1.2.6 Olmesartan
1.3 Global AT1 Receptor Antagonists Market Size by Type
1.3.1 Global AT1 Receptor Antagonists Sales and Growth by Type
1.3.2 Global AT1 Receptor Antagonists Sales and Market Share by Type (2014-2019)
1.3.3 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2014-2019)
1.3.4 Global AT1 Receptor Antagonists Price by Type (2014-2019)
2 Global AT1 Receptor Antagonists Market Competition by Company
2.1 Global AT1 Receptor Antagonists Sales and Market Share by Company (2014-2019)
2.2 Global AT1 Receptor Antagonists Revenue and Share by Company (2014-2019)
2.3 Global AT1 Receptor Antagonists Price by Company (2014-2019)
2.4 Global Top Players AT1 Receptor Antagonists Manufacturing Base Distribution, Sales Area, Product Types
2.5 AT1 Receptor Antagonists Market Competitive Situation and Trends
2.5.1 AT1 Receptor Antagonists Market Concentration Rate
2.5.2 Global AT1 Receptor Antagonists Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 AT1 Receptor Antagonists Company Profiles and Sales Data
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.1.3 Pfizer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Novartis
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.2.3 Novartis AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Merck
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.3.3 Merck AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Astra Zeneca
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Jhonson and Johnson
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Eli Lilly
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.6.3 Eli Lilly AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Sanofi
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.7.3 Sanofi AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Bristol-Myers Squibb
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Bayer
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 GSK
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.10.3 GSK AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Teva Pharmaceutical
4 AT1 Receptor Antagonists Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global AT1 Receptor Antagonists Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global AT1 Receptor Antagonists Sales and Revenue by Regions
4.2.1 Global AT1 Receptor Antagonists Sales and Market Share by Regions (2014-2019)
4.2.2 Global AT1 Receptor Antagonists Revenue and Market Share by Regions (2014-2019)
4.2.3 Global AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 AT1 Receptor Antagonists Application/End Users
5.1 AT1 Receptor Antagonists Segment by Application
5.1.1 Hypertension
5.1.2 Cardiovascular Diseases
5.1.3 Kidney Diseases
5.1.4 Other
5.2 Global AT1 Receptor Antagonists Product Segment by Application
5.2.1 Global AT1 Receptor Antagonists Sales by Application
5.2.2 Global AT1 Receptor Antagonists Sales and Market Share by Application (2014-2019)
6 Global AT1 Receptor Antagonists Market Forecast
6.1 Global AT1 Receptor Antagonists Sales, Revenue Forecast (2019-2026)
6.1.1 Global AT1 Receptor Antagonists Sales and Growth Rate Forecast (2019-2026)
6.1.1 Global AT1 Receptor Antagonists Revenue and Growth Rate Forecast (2019-2026)
6.2 Global AT1 Receptor Antagonists Forecast by Regions
6.2.1 North America AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.2 Europe AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.3 Asia-Pacific AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.5 Middle East and Africa AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 AT1 Receptor Antagonists Forecast by Type
6.3.1 Global AT1 Receptor Antagonists Sales and Revenue Forecast by Type (2019-2026)
6.3.2 Valsartan Gowth Forecast
6.3.3 Telmisartan Gowth Forecast
6.4 AT1 Receptor Antagonists Forecast by Application
6.4.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2019-2026)
6.4.2 Global AT1 Receptor Antagonists Forecast in Hypertension
6.4.3 Global AT1 Receptor Antagonists Forecast in Cardiovascular Diseases
7 AT1 Receptor Antagonists Upstream Raw Materials
7.1 AT1 Receptor Antagonists Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 AT1 Receptor Antagonists Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure AT1 Receptor Antagonists Product Picture
Figure Global AT1 Receptor Antagonists Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global AT1 Receptor Antagonists Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Valsartan
Table Major Players of Valsartan
Figure Global Valsartan Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Telmisartan
Table Major Players of Telmisartan
Figure Global Telmisartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Losartan
Table Major Players of Losartan
Figure Global Losartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Irbesartan
Table Major Players of Irbesartan
Figure Global Irbesartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Azilsartan
Table Major Players of Azilsartan
Figure Global Azilsartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Olmesartan
Table Major Players of Olmesartan
Figure Global Olmesartan Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global AT1 Receptor Antagonists Sales (K Units) by Type (2014-2019)
Table Global AT1 Receptor Antagonists Sales Share (%) by Type (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Type (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Type in 2018
Table Global AT1 Receptor Antagonists Revenue (Million USD) by Type (2014-2019)
Table Global AT1 Receptor Antagonists Revenue Share (%) by Type (2014-2019)
Figure Global AT1 Receptor Antagonists Revenue Share (%) by Type (2014-2019)
Figure 2018 Global AT1 Receptor Antagonists Revenue Market Share (%) by Type
Table Global AT1 Receptor Antagonists Price (USD/Unit) by Type (2014-2019)
Table Global AT1 Receptor Antagonists Sales (K Units) by Company (2014-2019)
Table Global AT1 Receptor Antagonists Sales Share (%) by Company (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Share (%) by Company in 2018
Table Global AT1 Receptor Antagonists Revenue (Million USD) by Company (2014-2019)
Table Global AT1 Receptor Antagonists Revenue Share (%) by Company (2014-2019)
Figure Global AT1 Receptor Antagonists Revenue Share (%) by Company in 2018
Table Global Market AT1 Receptor Antagonists Average Price (USD/Unit) by Company (2014-2019)
Table Global AT1 Receptor Antagonists Top Players Manufacturing Base Distribution and Sales Area
Table Global AT1 Receptor Antagonists Top Players Product Category
Figure Global AT1 Receptor Antagonists Market Share (%) of Top 5 Players
Figure Global AT1 Receptor Antagonists Market Share (%) of Top 10 Players
Table Pfizer Basic Information List
Table Pfizer AT1 Receptor Antagonists Product Category, Application and Specification
Table Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Pfizer AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Novartis Basic Information List
Figure Novartis AT1 Receptor Antagonists Product Category, Application and Specification
Table Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Novartis AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Novartis AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Merck Basic Information List
Figure Merck AT1 Receptor Antagonists Product Category, Application and Specification
Table Merck AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Merck AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Merck AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Astra Zeneca Basic Information List
Figure Astra Zeneca AT1 Receptor Antagonists Product Category, Application and Specification
Table Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Astra Zeneca AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Astra Zeneca AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Jhonson and Johnson Basic Information List
Figure Jhonson and Johnson AT1 Receptor Antagonists Product Category, Application and Specification
Table Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Jhonson and Johnson AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Jhonson and Johnson AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Eli Lilly Basic Information List
Figure Eli Lilly AT1 Receptor Antagonists Product Category, Application and Specification
Table Eli Lilly AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eli Lilly AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Eli Lilly AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Sanofi Basic Information List
Figure Sanofi AT1 Receptor Antagonists Product Category, Application and Specification
Table Sanofi AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Sanofi AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Sanofi AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Bristol-Myers Squibb Basic Information List
Figure Bristol-Myers Squibb AT1 Receptor Antagonists Product Category, Application and Specification
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bristol-Myers Squibb AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Bristol-Myers Squibb AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Bayer Basic Information List
Figure Bayer AT1 Receptor Antagonists Product Category, Application and Specification
Table Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bayer AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Bayer AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table GSK Basic Information List
Figure GSK AT1 Receptor Antagonists Product Category, Application and Specification
Table GSK AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure GSK AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure GSK AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Teva Pharmaceutical Basic Information List
Table Global AT1 Receptor Antagonists Market Size Comparison by Regions (2014-2025)
Figure North America AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global AT1 Receptor Antagonists Sales (K Units) by Regions (2014-2019)
Table Global AT1 Receptor Antagonists Sales Market Share (%) by Regions (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global AT1 Receptor Antagonists Sales Market Share (%) by Regions
Table Global AT1 Receptor Antagonists Revenue (Million USD) by Regions (2014-2019)
Table Global AT1 Receptor Antagonists Revenue Market Share (%) by Regions (2014-2019)
Figure Global AT1 Receptor Antagonists Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global AT1 Receptor Antagonists Revenue Market Share (%) by Regions
Table Global AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America AT1 Receptor Antagonists Sales Growth Rate
Table North America AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure United States AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Canada AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Canada AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Mexico AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Mexico AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Europe AT1 Receptor Antagonists Sales Growth Rate
Table Europe AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Germany AT1 Receptor Antagonists Revenue (Million USD) (2014-2019)
Figure UK AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure UK AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure France AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure France AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Italy AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Italy AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Russia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Russia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Turkey AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Turkey AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Asia-Pacific AT1 Receptor Antagonists Sales Growth Rate
Table Asia-Pacific AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure China AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Japan AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Japan AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Korea AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Korea AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Southeast Asia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Southeast Asia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Indonesia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Indonesia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Thailand AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Thailand AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Malaysia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Malaysia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Philippines AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Philippines AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Vietnam AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Vietnam AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure India AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure India AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Australia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Australia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure South America AT1 Receptor Antagonists Sales Growth Rate
Table South America AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Brazil AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate
Table Middle East and Africa AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure North Africa AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure GCC Countries AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure GCC Countries AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Hypertension Examples
Figure Cardiovascular Diseases Examples
Figure Kidney Diseases Examples
Figure Other Examples
Table Global AT1 Receptor Antagonists Sales (K Units) Comparison by Application (2014-2025)
Table Global AT1 Receptor Antagonists Sales (K Units) by Application (2014-2019)
Table Global AT1 Receptor Antagonists Sales Share (%) by Application (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Application (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Application in 2018
Figure Global AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global AT1 Receptor Antagonists Sales (K Units) Forecast by Regions (2019-2025)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global AT1 Receptor Antagonists Sales (Million USD) Forecast by Type (2019-2025)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) Forecast by Type (2019-2025)
Table Global AT1 Receptor Antagonists Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global AT1 Receptor Antagonists Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Valsartan Sales Growth Forecast
Figure Telmisartan Sales Growth Forecast
Table Global AT1 Receptor Antagonists Sales (K Units) Forecast by Application (2019-2025)
Figure Global AT1 Receptor Antagonists Sales Forecast by Application (2019-2025)
Figure Global AT1 Receptor Antagonists Sales (K Units) Forecast in Hypertension
Figure Global AT1 Receptor Antagonists Sales (K Units) Forecast in Cardiovascular Diseases
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure AT1 Receptor Antagonists Manufacturing Cost Structure
Figure AT1 Receptor Antagonists Industrial Chain Analysis
Table Distributors List
Table AT1 Receptor Antagonists Downstream Customers
1 AT1 Receptor Antagonists Market Overview
1.1 AT1 Receptor Antagonists Product Overview
1.2 AT1 Receptor Antagonists Market Segment by Type
1.2.1 Valsartan
1.2.2 Telmisartan
1.2.3 Losartan
1.2.4 Irbesartan
1.2.5 Azilsartan
1.2.6 Olmesartan
1.3 Global AT1 Receptor Antagonists Market Size by Type
1.3.1 Global AT1 Receptor Antagonists Sales and Growth by Type
1.3.2 Global AT1 Receptor Antagonists Sales and Market Share by Type (2014-2019)
1.3.3 Global AT1 Receptor Antagonists Revenue and Market Share by Type (2014-2019)
1.3.4 Global AT1 Receptor Antagonists Price by Type (2014-2019)
2 Global AT1 Receptor Antagonists Market Competition by Company
2.1 Global AT1 Receptor Antagonists Sales and Market Share by Company (2014-2019)
2.2 Global AT1 Receptor Antagonists Revenue and Share by Company (2014-2019)
2.3 Global AT1 Receptor Antagonists Price by Company (2014-2019)
2.4 Global Top Players AT1 Receptor Antagonists Manufacturing Base Distribution, Sales Area, Product Types
2.5 AT1 Receptor Antagonists Market Competitive Situation and Trends
2.5.1 AT1 Receptor Antagonists Market Concentration Rate
2.5.2 Global AT1 Receptor Antagonists Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 AT1 Receptor Antagonists Company Profiles and Sales Data
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.1.3 Pfizer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Novartis
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.2.3 Novartis AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Merck
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.3.3 Merck AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Astra Zeneca
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Jhonson and Johnson
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Eli Lilly
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.6.3 Eli Lilly AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Sanofi
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.7.3 Sanofi AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Bristol-Myers Squibb
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Bayer
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 GSK
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 AT1 Receptor Antagonists Product Category, Application and Specification
3.10.3 GSK AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Teva Pharmaceutical
4 AT1 Receptor Antagonists Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global AT1 Receptor Antagonists Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global AT1 Receptor Antagonists Sales and Revenue by Regions
4.2.1 Global AT1 Receptor Antagonists Sales and Market Share by Regions (2014-2019)
4.2.2 Global AT1 Receptor Antagonists Revenue and Market Share by Regions (2014-2019)
4.2.3 Global AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa AT1 Receptor Antagonists Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 AT1 Receptor Antagonists Application/End Users
5.1 AT1 Receptor Antagonists Segment by Application
5.1.1 Hypertension
5.1.2 Cardiovascular Diseases
5.1.3 Kidney Diseases
5.1.4 Other
5.2 Global AT1 Receptor Antagonists Product Segment by Application
5.2.1 Global AT1 Receptor Antagonists Sales by Application
5.2.2 Global AT1 Receptor Antagonists Sales and Market Share by Application (2014-2019)
6 Global AT1 Receptor Antagonists Market Forecast
6.1 Global AT1 Receptor Antagonists Sales, Revenue Forecast (2019-2026)
6.1.1 Global AT1 Receptor Antagonists Sales and Growth Rate Forecast (2019-2026)
6.1.1 Global AT1 Receptor Antagonists Revenue and Growth Rate Forecast (2019-2026)
6.2 Global AT1 Receptor Antagonists Forecast by Regions
6.2.1 North America AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.2 Europe AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.3 Asia-Pacific AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.5 Middle East and Africa AT1 Receptor Antagonists Sales and Revenue Forecast (2019-2026)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 AT1 Receptor Antagonists Forecast by Type
6.3.1 Global AT1 Receptor Antagonists Sales and Revenue Forecast by Type (2019-2026)
6.3.2 Valsartan Gowth Forecast
6.3.3 Telmisartan Gowth Forecast
6.4 AT1 Receptor Antagonists Forecast by Application
6.4.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2019-2026)
6.4.2 Global AT1 Receptor Antagonists Forecast in Hypertension
6.4.3 Global AT1 Receptor Antagonists Forecast in Cardiovascular Diseases
7 AT1 Receptor Antagonists Upstream Raw Materials
7.1 AT1 Receptor Antagonists Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 AT1 Receptor Antagonists Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
List of Tables and Figures
Figure AT1 Receptor Antagonists Product Picture
Figure Global AT1 Receptor Antagonists Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global AT1 Receptor Antagonists Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Valsartan
Table Major Players of Valsartan
Figure Global Valsartan Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Telmisartan
Table Major Players of Telmisartan
Figure Global Telmisartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Losartan
Table Major Players of Losartan
Figure Global Losartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Irbesartan
Table Major Players of Irbesartan
Figure Global Irbesartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Azilsartan
Table Major Players of Azilsartan
Figure Global Azilsartan Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Olmesartan
Table Major Players of Olmesartan
Figure Global Olmesartan Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global AT1 Receptor Antagonists Sales (K Units) by Type (2014-2019)
Table Global AT1 Receptor Antagonists Sales Share (%) by Type (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Type (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Type in 2018
Table Global AT1 Receptor Antagonists Revenue (Million USD) by Type (2014-2019)
Table Global AT1 Receptor Antagonists Revenue Share (%) by Type (2014-2019)
Figure Global AT1 Receptor Antagonists Revenue Share (%) by Type (2014-2019)
Figure 2018 Global AT1 Receptor Antagonists Revenue Market Share (%) by Type
Table Global AT1 Receptor Antagonists Price (USD/Unit) by Type (2014-2019)
Table Global AT1 Receptor Antagonists Sales (K Units) by Company (2014-2019)
Table Global AT1 Receptor Antagonists Sales Share (%) by Company (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Share (%) by Company in 2018
Table Global AT1 Receptor Antagonists Revenue (Million USD) by Company (2014-2019)
Table Global AT1 Receptor Antagonists Revenue Share (%) by Company (2014-2019)
Figure Global AT1 Receptor Antagonists Revenue Share (%) by Company in 2018
Table Global Market AT1 Receptor Antagonists Average Price (USD/Unit) by Company (2014-2019)
Table Global AT1 Receptor Antagonists Top Players Manufacturing Base Distribution and Sales Area
Table Global AT1 Receptor Antagonists Top Players Product Category
Figure Global AT1 Receptor Antagonists Market Share (%) of Top 5 Players
Figure Global AT1 Receptor Antagonists Market Share (%) of Top 10 Players
Table Pfizer Basic Information List
Table Pfizer AT1 Receptor Antagonists Product Category, Application and Specification
Table Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Pfizer AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Pfizer AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Novartis Basic Information List
Figure Novartis AT1 Receptor Antagonists Product Category, Application and Specification
Table Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Novartis AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Novartis AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Merck Basic Information List
Figure Merck AT1 Receptor Antagonists Product Category, Application and Specification
Table Merck AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Merck AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Merck AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Astra Zeneca Basic Information List
Figure Astra Zeneca AT1 Receptor Antagonists Product Category, Application and Specification
Table Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Astra Zeneca AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Astra Zeneca AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Jhonson and Johnson Basic Information List
Figure Jhonson and Johnson AT1 Receptor Antagonists Product Category, Application and Specification
Table Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Jhonson and Johnson AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Jhonson and Johnson AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Eli Lilly Basic Information List
Figure Eli Lilly AT1 Receptor Antagonists Product Category, Application and Specification
Table Eli Lilly AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eli Lilly AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Eli Lilly AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Sanofi Basic Information List
Figure Sanofi AT1 Receptor Antagonists Product Category, Application and Specification
Table Sanofi AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Sanofi AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Sanofi AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Bristol-Myers Squibb Basic Information List
Figure Bristol-Myers Squibb AT1 Receptor Antagonists Product Category, Application and Specification
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bristol-Myers Squibb AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Bristol-Myers Squibb AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Bayer Basic Information List
Figure Bayer AT1 Receptor Antagonists Product Category, Application and Specification
Table Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bayer AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure Bayer AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table GSK Basic Information List
Figure GSK AT1 Receptor Antagonists Product Category, Application and Specification
Table GSK AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure GSK AT1 Receptor Antagonists Sales Growth Rate (2014-2019)
Figure GSK AT1 Receptor Antagonists Sales Global Market Share (%)(2014-2019)
Table Teva Pharmaceutical Basic Information List
Table Global AT1 Receptor Antagonists Market Size Comparison by Regions (2014-2025)
Figure North America AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global AT1 Receptor Antagonists Sales (K Units) by Regions (2014-2019)
Table Global AT1 Receptor Antagonists Sales Market Share (%) by Regions (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global AT1 Receptor Antagonists Sales Market Share (%) by Regions
Table Global AT1 Receptor Antagonists Revenue (Million USD) by Regions (2014-2019)
Table Global AT1 Receptor Antagonists Revenue Market Share (%) by Regions (2014-2019)
Figure Global AT1 Receptor Antagonists Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global AT1 Receptor Antagonists Revenue Market Share (%) by Regions
Table Global AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America AT1 Receptor Antagonists Sales Growth Rate
Table North America AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure United States AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Canada AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Canada AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Mexico AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Mexico AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Europe AT1 Receptor Antagonists Sales Growth Rate
Table Europe AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Germany AT1 Receptor Antagonists Revenue (Million USD) (2014-2019)
Figure UK AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure UK AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure France AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure France AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Italy AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Italy AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Russia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Russia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Turkey AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Turkey AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Asia-Pacific AT1 Receptor Antagonists Sales Growth Rate
Table Asia-Pacific AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure China AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Japan AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Japan AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Korea AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Korea AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Southeast Asia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Southeast Asia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Indonesia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Indonesia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Thailand AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Thailand AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Malaysia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Malaysia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Philippines AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Philippines AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Vietnam AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Vietnam AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure India AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure India AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Australia AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Australia AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure South America AT1 Receptor Antagonists Sales Growth Rate
Table South America AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure Brazil AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate
Table Middle East and Africa AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure North Africa AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure GCC Countries AT1 Receptor Antagonists Sales (K Units)(2014-2019)
Figure GCC Countries AT1 Receptor Antagonists Revenue (Million USD)(2014-2019)
Figure Hypertension Examples
Figure Cardiovascular Diseases Examples
Figure Kidney Diseases Examples
Figure Other Examples
Table Global AT1 Receptor Antagonists Sales (K Units) Comparison by Application (2014-2025)
Table Global AT1 Receptor Antagonists Sales (K Units) by Application (2014-2019)
Table Global AT1 Receptor Antagonists Sales Share (%) by Application (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Application (2014-2019)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) by Application in 2018
Figure Global AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global AT1 Receptor Antagonists Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global AT1 Receptor Antagonists Sales (K Units) Forecast by Regions (2019-2025)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries AT1 Receptor Antagonists Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries AT1 Receptor Antagonists Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global AT1 Receptor Antagonists Sales (Million USD) Forecast by Type (2019-2025)
Figure Global AT1 Receptor Antagonists Sales Market Share (%) Forecast by Type (2019-2025)
Table Global AT1 Receptor Antagonists Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global AT1 Receptor Antagonists Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Valsartan Sales Growth Forecast
Figure Telmisartan Sales Growth Forecast
Table Global AT1 Receptor Antagonists Sales (K Units) Forecast by Application (2019-2025)
Figure Global AT1 Receptor Antagonists Sales Forecast by Application (2019-2025)
Figure Global AT1 Receptor Antagonists Sales (K Units) Forecast in Hypertension
Figure Global AT1 Receptor Antagonists Sales (K Units) Forecast in Cardiovascular Diseases
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure AT1 Receptor Antagonists Manufacturing Cost Structure
Figure AT1 Receptor Antagonists Industrial Chain Analysis
Table Distributors List
Table AT1 Receptor Antagonists Downstream Customers
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"